Global Certificate in Biopharma IP Transactions and Due Diligence
-- ViewingNowThe Global Certificate in Biopharma IP Transactions and Due Diligence is a comprehensive course designed to empower professionals with the essential skills required in the biopharma industry. This course highlights the importance of intellectual property (IP) transactions and due diligence in the biopharma sector, an area that is increasingly critical for career advancement.
4,322+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Biopharma Intellectual Property (IP) Landscape
⢠Understanding Patent Laws and Regulations
⢠IP Portfolio Management in Biopharma Industry
⢠Due Diligence in Biopharma IP Transactions
⢠Identifying and Evaluating IP Assets in Biopharma
⢠Contract Negotiation and Drafting in Biopharma IP Transactions
⢠Biopharma Licensing Agreements and Technology Transfers
⢠IP Valuation and Financial Analysis in Biopharma Transactions
⢠Managing Risks and Disputes in Biopharma IP Transactions
⢠Best Practices in Biopharma IP Transactions and Due Diligence
ę˛˝ë Ľ 경ëĄ
Patent attorneys handle the legal aspects of a biopharma company's IP, including patent applications, litigation, and licensing. Their expertise ensures that the company's inventions and innovations are protected, allowing for a competitive edge in the market. - **IP Lawyer**:
IP lawyers deal with a wide range of legal matters related to IP, such as copyrights, trademarks, and patents. They assist biopharma companies in navigating the complex legal landscape and making informed decisions about their IP assets. - **Biopharma Licensing Specialist**:
Licensing specialists facilitate the licensing of IP assets between different entities in the biopharma industry. They negotiate deals, draft contracts, and ensure that all parties comply with the agreed terms, maximizing the value of the company's IP portfolio. - **Due Diligence Analyst**:
Due diligence analysts specialize in assessing a company's IP assets during mergers, acquisitions, or partnerships. They evaluate the strength of the IP portfolio, potential legal issues, and the overall value of the IP assets, helping the company make informed strategic decisions.
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëŹ¸
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë
